Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Accounting and Finance

Marketing

Sales

Human Resources

Public Sector and Government

Product Management

Arts and Entertainment

Senior Vice President, Clinical Data Science

Executive Vice President, Commercial Operations

Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Gilead Sciences To Release Third Quarter 2025 Financial Results On Thursday, October 30, 2025

Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Expedition Therapeutics Raises $165 Million in Oversubscribed Series A Financing to Advance Next-Generation DPP1 inhibitor for COPD

Associate Director, Generative AI

Gilead Sciences is dedicated to creating a healthier world by tackling significant health challenges. As the Associate Director of Generative AI, you will lead the development of AI solutions across commercial functions, ensuring alignment with regulatory frameworks and fostering cross-functional collaboration to maximize business value.

Sign up with Google

Sign in with Google